New drug for psoriatic arthritis

Cimzia® (certolizumab pegol), in combination with methotrexate, has been launched in the UK for the treatment of active psoriatic arthritis in adults when the response to previous disease-modifying antirheumatic drugs has been inadequate.Psoriatic arthritis is an inflammatory condition which is associated with the skin disorder psoriasis and can affect the joints as well as the nails and tendons. It is estimated that up to 156,000 people in England and Wales are affected by this condition and if left untreated, it can lead to significant joint damage and disability over time. People diagnosed with psoriatic arthritis usually experience a combination of